Song et al. has used GM1 modified nanodiscs to load neuroprotective NAP peptide for intranasal administration in AD model mice and observed efficient distribution of NAP peptide in the mice brain, reduced Aβ aggregate deposition and amelioration of neurological deficits, such as memory loss (Song et al., 2016). The gene discussed is CTNNBL1; the disease is Alzheimer disease.